about
Partial nephrectomy versus radical nephrectomy for clinically localized renal massesSmall renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategiesIndications for biopsy and the current status of focal therapy for renal tumoursStereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell CarcinomaThe Past, Present, and Future in Management of Small Renal MassesRobotic-Assisted Renal SurgeryMolecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?Percutaneous ablation for small renal masses-complicationsRisk of chronic kidney disease after nephrectomy for renal cell carcinomaImaging management of incidentally detected small renal masses.Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaRobotic partial nephrectomy: current technique and outcomesCurrent status of renal biopsy for small renal massesCancer concepts and principles: primer for the interventional oncologist-part IIThe clinical application of the sliding loop technique for renorrhaphy during robot-assisted laparoscopic partial nephrectomy: Surgical technique and outcomesPredictive factors of prolonged warm ischemic time (≥30 minutes) during partial nephrectomy under pneumoperitoneum.Medical hyperspectral imaging: a review.Epidemiology of the Small Renal Mass and the Treatment Disconnect Phenomenon.Renal cell carcinoma.Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta-analysis of clinically localized renal masses suspicious for malignancy.Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-AnalysisPercutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.Modeling Cryotherapy Ice Ball Dimensions and Isotherms in a Novel Gel-based Model to Determine Optimal Cryo-needle Configurations and Settings for Potential Use in Clinical Practice.Renal ablation using magnetic resonance-guided high intensity focused ultrasound: Magnetic resonance imaging and histopathology assessment.Histotripsy methods in mechanical disintegration of tissue: towards clinical applicationsRenal ablation update.Ablative therapies for renal tumorsOverall survival advantage with partial nephrectomy: a bias of observational data?Ethical Issues in the Management of Renal Cell Carcinoma.Ipsilateral renal function preservation after robot-assisted partial nephrectomy (RAPN): an objective analysis using mercapto-acetyltriglycine (MAG3) renal scan data and volumetric assessment.Clinical applications of optical coherence tomography in urology.3D printed renal cancer models derived from MRI data: application in pre-surgical planning.Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.Renal cell carcinoma needle biopsy: sowing the seed for later complications?Perioperative complications and postoperative outcomes of partial nephrectomy for renal cell carcinoma: Does indication matter?Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment.Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.Optimal freeze cycle length for renal cryotherapyAre multiple cryoprobes additive or synergistic in renal cryotherapy?Peritumoral Artery Scoring System: a Novel Scoring System to Predict Renal Function Outcome after Laparoscopic Partial Nephrectomy
P2860
Q24186190-AED4ED96-BD11-467D-9BA5-35B9F8A21C22Q26738778-CD153F9D-8FA5-49E2-BBBD-75BA3A00AAA6Q26773659-FFCCCF75-FD1D-43E0-BC35-CA508446B271Q26774094-66A2805C-A725-4AE2-B610-51B861540CC9Q26778402-55B043D7-DBC6-4893-94F5-A2D9461030DAQ26782253-C5A41C85-B8A0-4626-A6A9-4D36AF333F07Q26825512-264FA126-1A99-4E19-9CAC-1CF462D8773BQ26829803-CDE24F24-5E70-4677-8AF2-41FBB54CA0CDQ26862825-3B68CC81-BBF7-405B-A8C4-5DD7C7FD16F3Q26862876-3083516F-D98F-463F-A344-6C3E7CA19DD5Q26863402-E7CC90CB-D345-4A2C-9ADD-7F31299F2450Q27004518-3469BA80-D679-4285-B5E4-A4C890F4A079Q27010138-CF8A666A-8541-45EB-9506-FC3C024ACA7DQ27010961-428DCC99-1DAD-48DD-B06E-66FA0FF67DCFQ27302120-AF65BEB8-993A-4F77-9569-2DFB877E0898Q27302133-A91C73D3-EF4F-4CA2-B17D-C8CAB6A2831DQ28306103-F5F71EAE-9570-43A1-A621-053980B4EBC2Q30234788-555E449A-FAAC-436F-8D85-67D0603C996CQ30235364-588A74B2-AFA3-4249-9D7B-BEE3AF542AF7Q30244371-A98B1B5D-4D8A-46B2-97D0-1DDDDB39FCE8Q30251380-E596368F-96C3-4575-AAF7-FC13B40782F8Q30276826-A8FC1392-D968-4CEB-8D5D-99C643624BC7Q30384095-A33D17C0-CA84-4430-979A-154AC9F695A6Q30387495-FD26FB42-E4DD-439A-8D47-380484107D44Q30389693-8B0BBBDD-81F6-4932-8C36-A9E646A7B421Q30410582-CB2FADF1-9C81-4836-A0E1-6640E9F73257Q30474742-A0A00DE8-5255-4892-ACCC-5A500956A6DFQ30626270-5E657DF8-2193-4159-A1BF-38C229800927Q30724257-CB11E127-1886-4A2F-93CE-D8DEEDF40714Q30829495-DE95E345-A46F-4A3D-97F4-9EDD2AF254AEQ30838887-452BE747-23D8-4109-8401-8BA728B52CD1Q31153415-6CC6C913-325E-4D5B-BFCB-8EF69594D4F8Q31163345-487D3540-DBBF-47E7-AE8E-A1D2F8B2BC64Q33565491-E1457A00-F6AC-40D0-89A2-64E75A8215FBQ33578573-C058EFBC-A4ED-43F7-92FD-1713E5514675Q33648589-39A9318E-291A-415C-B001-78D4B062924AQ33683920-6C7FDA6A-7C05-4E7C-89C7-6D087B3F998BQ33699705-354830F7-12F1-4413-9157-33214A429FD7Q33733291-89F267AD-E8E9-4B24-BD8E-9800BF36F304Q33767501-CF0206CE-ABE3-44CF-B801-460BFC6F8BFF
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Guideline for management of the clinical T1 renal mass.
@ast
Guideline for management of the clinical T1 renal mass.
@en
Guideline for management of the clinical T1 renal mass.
@nl
type
label
Guideline for management of the clinical T1 renal mass.
@ast
Guideline for management of the clinical T1 renal mass.
@en
Guideline for management of the clinical T1 renal mass.
@nl
prefLabel
Guideline for management of the clinical T1 renal mass.
@ast
Guideline for management of the clinical T1 renal mass.
@en
Guideline for management of the clinical T1 renal mass.
@nl
P2093
P1476
Guideline for management of the clinical T1 renal mass.
@en
P2093
Andrew C Novick
Arie Belldegrun
George K Chow
Ithaar H Derweesh
Jihad H Kaouk
Martha M Faraday
Michael L Blute
Paul Russo
Practice Guidelines Committee of the American Urological Association
Raymond J Leveillee
P304
P356
10.1016/J.JURO.2009.07.004
P407
P577
2009-08-14T00:00:00Z